Milki A A, Hinckley M D, Fisch J D, Dasig D, Behr B
Department of Gynecology and Obstetrics, Stanford University School of Medicine, California 94305, USA.
Fertil Steril. 2000 Jan;73(1):126-9. doi: 10.1016/s0015-0282(99)00485-9.
To compare implantation and pregnancy rates (PRs) achieved with blastocyst transfer (BT) and day 3 ET in similar patient populations.
Retrospective analysis.
Academic infertility center.
PATIENT(S): One hundred consecutive patients <40 years undergoing IVF, each with more than three eight-cell embryos on day 3.
INTERVENTION(S): Patients used their own eggs for IVF or IVF and intracytoplasmic sperm injection. Embryos were cultured in P1 medium (Irvine Scientific, Santa Ana, CA) until day 3, when they were either transferred or, in the case of embryos for BT, incubated in Blastocyst Medium (Irvine Scientific), followed by transferring on day 5.
MAIN OUTCOME MEASURE(S): Implantation and PRs.
RESULT(S): There were no statistically significant differences in patient age, FSH level, or number of oocytes or zygotes. The BT group had fewer embryos transferred (mean, 2.4) compared with the day 3-ET group (mean, 4.6). The viable PR (cardiac activity at 6-7 weeks was considered indicative of a viable pregnancy) was higher with BT (68%, 34/50) than with day 3 ET (46%, 23/50). The implantation rate was increased with BT (47%, 56 sacs/120 embryos) compared with day 3 ET (20%, 46 sacs/231 embryos).
CONCLUSION(S): The BT group in our study had higher implantation and PRs compared with the day 3-ET group. Better embryo selection, improved embryo-uterine synchrony, and decreased cervical mucus on day 5 may have accounted for the enhanced outcome. Our data support the use of BT to limit the number of embryos transferred while improving PRs.
比较在相似患者群体中,囊胚移植(BT)和第3天胚胎移植(ET)的着床率和妊娠率(PRs)。
回顾性分析。
学术性不孕不育中心。
100例连续接受体外受精(IVF)且年龄小于40岁的患者,每位患者在第3天有超过3个八细胞胚胎。
患者使用自身卵子进行IVF或IVF与卵胞浆内单精子注射。胚胎在P1培养基(Irvine Scientific公司,加利福尼亚州圣安娜)中培养至第3天,此时要么进行移植,对于用于BT的胚胎,则在囊胚培养基(Irvine Scientific公司)中孵育,随后在第5天进行移植。
着床率和PRs。
患者年龄、促卵泡激素(FSH)水平、卵母细胞或受精卵数量方面无统计学显著差异。与第3天ET组(平均4.6个)相比,BT组移植的胚胎数量更少(平均2.4个)。BT组的活产妊娠率(6 - 7周时的心脏活动被视为活产妊娠的指标)高于第3天ET组(分别为68%,34/50和46%,23/50)。与第3天ET组(20%,46个囊胚/231个胚胎)相比,BT组的着床率有所提高(47%,56个囊胚/120个胚胎)。
我们研究中的BT组与第3天ET组相比,着床率和PRs更高。更好的胚胎选择、改善的胚胎 - 子宫同步性以及第5天宫颈黏液减少可能是结局改善的原因。我们的数据支持使用BT来限制移植胚胎数量,同时提高PRs。